The Truth About GLP-1s, Caring for Aging Parents, and When to Accelerate Your Career

“I think GLP-1s are going to be a more impactful technology than AI,” Scott Galloway says in this episode of The Prof G Pod, before fielding questions on the sandwich generation and career sequencing for working mothers. The throughline is a series of tradeoffs: between the undeniable benefits of a medical breakthrough and its manageable downsides, between supporting aging parents and protecting your own young family, and between accelerating a career now and being present for small children. Galloway’s answers are blunt, data-driven, and unapologetically capitalistic, but they are also grounded in his own experience and a clear-eyed view of how the world actually works.

The GLP-1 Tradeoff: Muscle Loss vs. a “Gift from God”

Responding to a listener’s concern about the 30–40% muscle loss associated with GLP-1 drugs, Galloway acknowledges the data but reframes it. He notes that similar ratios of lean mass loss occur with any rapid weight loss from calorie restriction, meaning the problem is not unique to the drugs. The risk is highest for older adults with low muscle reserves, but it is “largely manageable with resistance training and adequate protein intake.” He recommends bodyweight exercises like air squats and pushups to avoid the “draped skin look.”